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AhR-deficiency as a cause of 
demyelinating disease and 
inflammation
Ludmila Juricek1,6, Julie Carcaud2,6, Alice Pelhaitre1,6, Thorfinn T. Riday5,6, Aline Chevallier1,6, 
Justine Lanzini3,6, Nicolas Auzeil3,6, Olivier Laprévote3,6, Florent Dumont4,6, Sebastien 
Jacques4,6, Frank Letourneur4,6, Charbel Massaad1,6, Cendra Agulhon5,6, Robert Barouki1,6, 
Mathieu Beraneck2,6 & Xavier Coumoul1,6
The Aryl hydrocarbon Receptor(AhR) is among the most important receptors which bind pollutants; 
however it also regulates signaling pathways independently of such exposure. We previously 
demonstrated that AhR is expressed during development of the central nervous system(CNS) and that 
its deletion leads to the occurrence of a congenital nystagmus. Objectives of the present study are 
to decipher the origin of these deficits, and to identify the role of the AhR in the development of the 
CNS. We show that the AhR-knockout phenotype develops during early infancy together with deficits 
in visual-information-processing which are associated with an altered optic nerve myelin sheath, 
which exhibits modifications in its lipid composition and in the expression of myelin-associated-
glycoprotein(MAG), a cell adhesion molecule involved in myelin-maintenance and glia-axon interaction. 
In addition, we show that the expression of pro-inflammatory cytokines is increased in the impaired 
optic nerve and confirm that inflammation is causally related with an AhR-dependent decreased 
expression of MAG. Overall, our findings demonstrate the role of the AhR as a physiological regulator 
of myelination and inflammatory processes in the developing CNS. It identifies a mechanism by which 
environmental pollutants might influence CNS myelination and suggest AhR as a relevant drug target 
for demyelinating diseases.
The Aryl hydrocarbon Receptor (AhR), a ligand-activated transcription factor, belongs to the 
basic-Helix-Loop-Helix/Per-ARNT-Sim family that regulates detoxification1. Recent discoveries using knockout 
models have suggested that the AhR has distinct roles in mammalian physiology2, 3. The modulation of AhR 
expression causes defects during neuro-development in model organisms such as C. elegans. Although the AhR 
mRNA is expressed in various cerebral regions4–8, its role in the development and functions of the nervous system 
in vertebrates remains elusive. Previously, we have shown that the AhR-knockout (AhR-KO) adult mice display 
a spontaneous horizontal nystagmus of unknown origin9. In humans, the diagnosis and the characterization 
of the nystagmus have major clinical implications because it represents a predictive symptom of major central 
nervous system pathologies, including multiple sclerosis or Pelizaeus-Merzbacher disease10–13. Nystagmus is also 
encountered in specific neuro-developmental diseases grouped under the term of Infantile Nystagmus Syndrome 
(INS). The mechanisms involved in the establishment of such abnormal eye movements during development in 
infants have not yet been characterized because of their heterogeneity and of the lack of animal models14. We 
have previously shown that the origin of the nystagmus was not vestibular neither cerebellar, while the AhR was 
expressed in the eye during mice development. We have now extended our research at the cellular and molecular 
levels focusing our efforts on different characteristics of the visual circuitry, mostly anatomical and structural, and 
showed that the disease was in fact related to a significant demyelination of the optic nerves in the AhR-KO mice. 
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A multi-omics non-candidate approach then revealed that the mechanism of this demyelination is related to an 
inflammatory state of the optic nerve which impairs the expression of the myelin-associated glycoprotein (MAG) 
as demonstrated by in vivo and ex vivo approaches.
Overall, our study first reports the role of the AhR in the pathogenesis of demyelinating diseases associated 
with inflammation such as optic neuritis or multiple sclerosis, providing new avenues for the understanding and 
the treatment of nystagmus-related pathologies.
Results
Functional characterization of gaze–related pathways. AhR-KO mice exhibit a spontaneous pendu-
lar horizontal nystagmus (Fig. 1a), increased by the presence of visual inputs (Figure S1a)9. To determine whether 
it is acquired during postnatal development, video-oculography was performed on young mice (P26–40) (Figs 1b 
and S1b). At P26, the nystagmus was present in all AhR-KO mice, while it was never observed in WT-control 
mice. During the period of functional maturation of gaze stabilizing reflexes15, there was a significant increase 
of the amplitude of the oscillations (Figure S1b). These data demonstrate that AhR-KO congenital nystagmus 
appears early in development and worsens with aging. Next, we tested the functionality of the optomotor path-
ways (Figure S1c). While all available models have gross abnormalities in the optokinetic reflex11, 16, it was reduced 
but present and in compensatory direction in all tested AhR-KO mice (Figure S1c). Then, we checked whether the 
nystagmus could originate from anatomical defects as previous INS-models were shown to be achiasmatic17, 18. 
Examinations of the projections of the optic nerves to the thalamus demonstrated no anatomical differences 
between WT and AhR-KO mice (Figs 1c and S1d). Considering that nystagmus is often associated with visual 
deficits, we recorded visual evoked potentials (VEPs) from the primary visual cortex; we found that amplitudes 
were lower in adult AhR-KO vs. WT mice (Fig. 1d-left), indicating a deficit in the integration of visual informa-
tion. While we did not observe a significant difference in the initiation time of the VEPs between AhR-KO and 
WT groups, indicating that velocity conduction is preserved in AhR-KO mice (Fig. 1d-middle), the presentation 
of different visual stimuli demonstrated a ≈32% decrease in the sensitivity to contrast, but not in the visual acuity 
(Fig. 1d-right). This sensitivity appears to be critical for the mice to discriminate orientations19. These results 
demonstrate that the AhR-KO nystagmus is associated with a functional deficit in the early processing of visual 
information.
Figure 1. AhR knockout mice as a model of INS pathologies. (A) Raw traces of spontaneous eye movements 
recorded in the presence of light (8 week-old AhR-KO). (B) Nystagmus amplitude (degrees) and frequency (Hz) 
recorded at P26 and P40 (n = 8). (C) Example of whole brain staining of a WT and an AhR KO mouse: Optic 
Nerve (ON), Optic Chiasm (OC), Optic Tract (OT), Thalamus (Th) and Superior Colliculus (SC). (D) Left: 
Average Visually Evoked Potentials (VEP) traces recorded in WT (black line, n = 9) or AhR KO mice (blue line, 
n = 8) (100% contrast and 0.05 cpd stimulation). The white line represents the average and the envelope around 
(blue or black) represents the SEM. Middle: Initiation time of the VEPs measured on both WT (black bar) and 
AhR KO mice (blue bar). Right: VEP amplitudes with decreasing contrast stimulation or decreasing visual 
acuity (i.e. increasing spatial frequency). Dotted lines represent the noise. Arrows represent the first stimulation 
significantly different from the noise. (*p < 0.05; **p < 0.01).
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AhR KO mice display structural alterations of the myelin of optic nerves. Concomitantly, as 
nystagmus occurs frequently in demyelinating pathologies12, 13, 20, we hypothesized that AhR-KO mice could 
present structural alterations of the myelin sheath. Electron-microscopy analyses of the optic nerves revealed a 
disorganization of the myelin sheath of AhR-KO mice (Fig. 2a). Furthermore, the proportion of low-myelinated 
axons and the G-ratio, a structural index of optimal axonal myelination (Fig. 2b), were significantly increased in 
AhR-KO mice. As the myelin sheath is mainly composed of complex lipids and proteins, we then investigated its 
composition and performed a lipidomic analysis to determine if the structural defects were due to a modification 
in the lipid content. Subsequent univariate and multivariate analyses showed significant decreases for 28 lipids in 
AhR-KO vs. WT mice, especially the ceramides family (Table S1) which is specific of the central nervous system. 
Afterwards, we assayed the mRNA and protein expression of genes which play a crucial role in the formation 
of the myelin sheath in the optic nerve21: qRT-PCR analysis revealed a down-regulation of MAG mRNA levels 
in adult AhR-KO mice vs. WT mice, which was confirmed at the protein level (Fig. 2c, left). This effect is spe-
cific to MAG as the levels of myelin basic protein (MBP) and proteolipid-protein (PLP) mRNA levels remained 
unchanged between AhR-KO and WT mice (Fig. 2c, right). Altogether these results suggest that the alteration of 
the myelin sheath surrounding the neurons of the optic nerve could originate in the altered lipid content com-
bined with the down-regulation of MAG.
Pro-inflammatory cytokines are increased in the optic nerves of AhR KO mice. In order to iden-
tify the signaling pathways involved in all observed phenomenon at the functional, cellular and molecular lev-
els (nystagmus, demyelination, MAG expression), we investigated the transcriptomes of the AhR-KO and WT 
optic nerves. Heat map analysis revealed that 2366 genes were differentially (p < 0.05) expressed in AhR-KO 
mice (Figure S2a). Ingenuity Pathway Analysis identified inflammatory pathways among the top scoring inter-
action networks (Figure S2a). Hierarchical clustering suggested a central regulating role of Signal Transducers 
and Activators of Transcription 1 (STAT1) protein (Fig. 3a) which is activated for example by Tumor Necrosis 
Factor-α (TNFα) as demonstrated by the direct association of STAT1 with TNFα Receptor 122. Inflammation in 
the optic nerves of AhR-KO mice was confirmed by immunostaining showing an increase of the expression of the 
glial fibrillary acidic protein (GFAP) in astrocytes (Fig. 3b). In contrast, we did not observe a significant increase 
of the expression of Iba1 in microglia (Figure S2b). Moreover, the expression of pro-inflammatory cytokines 
and chemokines (Interleukine-1β, Regulated on Activated-Normal T-cell Expressed and Secreted; Monocyte 
Chemoattractant Protein 1–3; Tumor Necrosis Factor-α) genes significantly increased (Fig. 3c). To determine 
how the inflammatory environment affects the expression of myelin genes, we examined the effects of TNFα 
Figure 2. AhR deficiency leads to myelin alterations in the optic nerve. (A) Example of transverse ultrathin 
sections of the optic nerve of 8 weeks-old WT (left) and AhR KO (right) mice examined by transmission 
electron microscopy. Scale bars: 2 µm (top) or 0,5 µm (bottom). The yellow arrows indicate zones of 
disorganized myelin sheath. (B) Left: percentage of low-myelinated axons in the optic nerves of WT (n = 5, 
black bar) and AhR-KO (n = 5, blue bar) mice. Middle: Scatter plots depicting G-ratio (ratio of axon diameter/
myelinated fiber diameter) of WT (n = 352 axons, black) and AhR KO (n = 243 axons, blue) mice. Right: 
Quantification of the G-ratio of optic nerves for each genotype (n = 5 WT and n = 5 AhR KO). (C) Quantitative 
Real-Time PCR analysis of three myelin genes (MAG, MBP, PLP) in the WT (black bars) and AhR-KO (blue 
bars) mice optic nerves (n = 18–19/group). mRNA levels were normalized to GAPDH mRNA expression. 
Middle: MAG protein in whole tissue lysates of WT and AhR-KO mice optic nerves was detected by Western 
Blot. Total actin was used as a loading control (n = 4/group). A full-length gel is included in the supplementary 
file (complete western blot). MAG: myelin associated-glycoprotein; MBP: myelin basic protein; PLP: proteolipid 
protein; GAPDH: glyceraldehyde 3-phosphate dehydrogenase (*p < 0.05).
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Figure 3. AhR-dependent inflammatory response controls myelin genes. (A) Left: Heatmap of the annotated 
genes with the highest importance in inflammatory response. Red: increased mRNAs expression; green: 
decreased mRNA expression (n = 5/group). Right: Connected components of the relevance network after 
IPA. Thirteen gene probes were analyzed by IPA software and annotated for gene network construction. Both 
over-expressed and under-expressed genes were mapped to the same network space. The pathway analysis 
revealed a central regulating role for tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFNγ). Main 
components of the legend: hatched line: indirect interaction; continuous line: direct interaction; arrow: acts on; 
line with a perpendicular line at the end: inhibits; square: cytokine (Interferon-γ and TNF-α); horizontal oval 
(STAT1); transcription regulator; vertical oval (SFRP1): transmembrane receptor; vertical diamond (ASCL1): 
enzyme; horizontal diamond (CFB): peptidase; circle (Saa3): other. (B) Expression of immunoreactive GFAP, 
an astrocyte marker, in the optic nerve of WT (top) and AhR KO (bottom) adult mice (Scale bar: 100 µm, n = 4/
group). (C) Quantitative Real-Time PCR analysis of Interleukine-1β (IL1β), IL6, RANTES (Regulated on 
Activated Normal T-cell Expressed and Secreted), MCP1–3 (Monocyte Chemoattractant Protein 1–3), Tumor 
Necrosis Factor-α (TNF-α) in the WT (black bars) and AhR-KO (blue bars) mice optic nerves (n = 10–22/
group). mRNA levels were normalized to GAPDH mRNA expression. (D) Myelin genes (MAG, MBP and PLP) 
mRNA expression was determined by Quantitative Real-Time PCR analysis in primary mixed glial cell cultures 
after 3 days-treatment with TNFα (10 ng/mL), IFNγ (10 ng/mL) or both (concentration 10ng/mL of each) 
or vehicle (control). The relative mRNA expression levels were represented as relative fold change compared 
to mRNA abundance in cells treated with vehicle. Data are expressed as the mean of four to six independent 
experiments. Each experiment consists of pool of 2–8 pups. IPA: Ingenuity Pathway Analysis, GFAP: Glial 
Fibrillary Acidic Protein (***p < 0.001, **p < 0.01; *p < 0.05).
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and/or interferon-gamma (IFN-γ) which activates the STAT1 pathway22, alone or in combination, in mixed-glial 
cell cultures (which contain oligodendrocytes, expressing MAG and responsible for myelination) after 3 days of 
treatment (Fig. 3d). Interestingly, these two pro-inflammatory cytokines taken individually have no effects on 
MAG expression, whereas the co-treatment significantly decreases MAG mRNA expression by approximately 
60% only in AhR-KO mice, indicating that this down-regulation is AhR-dependent (Fig. 3d-left). Moreover, 
the co-treatment further increased the mRNA expression of most cytokines and chemokines studied, which 
demonstrates the existence of a positive feedback loop (Figure S2c) susceptible to further aggravate inflammation. 
Collectively, these data suggest a causal link between the expression of the AhR, the inflammatory process found 
in the optic nerves of AhR-KO mice, the reduction of MAG expression, and the myelin disruption.
Discussion
Our study has identified the AhR and its role in the myelination of the visual and optomotor pathways as a puta-
tive cause for Infantile Nystagmus Syndrome (INS). Hence, the AhR-KO is a developmental model which shares 
numerous features with the human pathology14. First, AhR KO mice display as early as on P26 a nystagmus that 
rapidly aggravates with age. Because of the initial low amplitude and low frequency of the eye movements, it would 
be difficult to detect any deficit beforehand; however, this result suggests that, as in infants, the nystagmus appears 
during early maturation of the visual system. Other characteristics of the AhR-KO phenotype resemble the INS: 
abnormal eye movements are essentially horizontal, aggravate with light or fixation attempts, and evolve with age. 
Finally, while previous animal models of INS were achiasmatic and had inverted optokinetic responses11, 16–18, 
we show that the AhR-KO mice has normal decussating retinal projections and show compensatory responses 
during optokinetic stimulation, both features observed in INS10. Interestingly, this study highlights, for the first 
time, that the AhR is involved in myelination of central nervous system. Fernandez et al. have shown that a single 
prenatal exposure to TCDD, an exogenous AhR ligand, could disturb the expression of oligodendrocyte markers 
during the rat brain development but did not investigate on the myelin structure23. In our model, the deletion 
of AhR provokes a severe disorganization of myelin sheath surrounding axons of retinal ganglion cells, indicat-
ing that this receptor plays an important role in myelin structure and maintenance. The strong and significant 
decrease of galactosylceramide (GalCer) concentrations measured by UPLC-MS in the optic nerve of AhR-KO 
mice suggest that modified ceramides might represent potential biomarkers of inflammatory diseases in the CNS 
as also suggested by Mayo et al. who characterized increased levels of lactosylceramide (LacCer) during chronic 
experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS)24. One of the first indi-
cators of MS in humans is a nystagmus. LacCer which is produced by β-1,4-galactosyltransferase 6 (whose levels 
increase in EAE) controls astrocyte and microglia activation and then promotes neurodegeneration24. Taken 
together these data demonstrate that an activation or a deletion of this receptor may interfere with physiological 
myelination process.
In addition to its alterations of the myelin structure of the optic nerves, AhR-KO mice also develop a local 
inflammatory environment. Indeed, microarrays studies have shown that AhR-KO mice display an inflammatory 
optic nerve resulting in the secretion of pro-inflammatory cytokines, which likely amplify the local inflamma-
tion. This is in line with other studies showing that the AhR-KO mice are inflammation prone. It was shown for 
instance, that these mice develop a severe form of experimental autoimmune encephalomyelitis25. Moreover, 
the AhR inhibits the transcription of NLRP3 which is important for the inflammasome activity26. In line with 
our study, TNF-alpha production is also significantly higher in AhR-deficient macrophages stimulated by the 
lipopolysacharride (LPS)27. Interestingly, an inflammation of the optic nerve, or optic neuritis, is often associated 
in humans with acquired demyelinating pathologies such as multiple sclerosis26 or leukodystrophies12, in which 
the nystagmus serves as a symptomatic biomarker and usually signs an inflammatory state14.
Recent studies have shown that myelin-related diseases can be associated with a 30% up- or down-regulation 
of myelin genes28, 29. This is also in line with our results, as we observed a >40% decrease of MAG expression. 
Moreover, MAG deficiency has been associated with the occurrence of a nystagmus in myelin-associated dis-
eases29. MAG is expressed by oligodendrocytes and regulates the myelin attachment to the neuron together with a 
signaling function. Because in our model the AhR was knocked-out in all neural cells, whether the myelin impair-
ment relates to the AhR-deficit specifically in the oligodendrocytes remains to be determined. Here, we demon-
strated for the first time, that the inflammatory environment, as the combination of TNF-alpha and IFN-gamma, 
is key in an AhR-deficient context to decrease the expression of MAG; interestingly, we also observe a strong 
modification of PLP mRNA expression in primary mixed glial cell cultures from both origins (WT and KO). In 
WT primary mixed glial cell cultures, the effect is primarily due to TNF-alpha as IFN-gamma did not impact 
the mRNA expression of PLP nor modify the effect of TNF-alpha. In KO primary mixed glial cell cultures, the 
effect is on the other hand primarily due to the mixture TNF-alpha and IFN-gamma. The significant effect of the 
cytokine mixture on MAG mRNA expression specifically in KO primary mixed glial cell cultures suggests that the 
KO phenotype sensitize the oligodendrocyte to the combined effects of both cytokines; this also strengthens our 
experiments on KO optic nerves and provides a mechanistic link explaining this decrease of expression: we can 
indeed hypothesize that the absence of the AhR leads to an inflammatory state characterized by an increase secre-
tion of TNF-alpha and IFN-gamma which decrease the expression of MAG. Several hypotheses could explain the 
differential effects on PLP expression observed when comparing optic nerves and primary glial cells: (1) the dose 
of cytokines used as a treatment on the primary glial cells might have been higher than in vivo, and would be suf-
ficient to promote a decreased expression of PLP compared to the concentrations in the optic nerve, which only 
acts on MAG expression. (2) the primary mixed glial cell culture is a model which is not fully representative of 
the in vivo situation as e.g. the lack of neurons, which could sensitize differentially the oligodendrocyte regarding 
PLP expression. These results nevertheless establish a causal link between the AHR, the occurrence of an inflam-
matory state, and the regulation of a myelin-associated proteins and that this potential link should be studied in 
the future, focusing on inflammatory-related pathologies of the central nervous system.
www.nature.com/scientificreports/
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Conclusions
Overall, the AhR-KO model clearly exhibit many cellular and functional features associated with inflammatory 
demyelinating diseases. Our observations indicate that the AhR represents a relevant pharmacological target in 
order to modulate inflammatory and demyelinating processes, providing new avenues for the understanding and 
the treatment of these pathologies in humans.
Methods
Mice. The European Communities Council Directive 2010/63/EU on the protection of animals was followed 
for the experiments using animals. All procedures were approved by the ethical committee for animal research 
of the University Paris Descartes (CEEA.34). AhR KO mice are a generous gift of Pr. PM Fernandez-Salguero30.
Video-oculography. Animals and surgery. Eye-movement recordings were performed on a total of 32 
mice, including 26 AhR KO and 6 AhR WT. Surgical preparation and postoperative care for head implant surgery 
have been described previously9. Briefly, Gas anesthesia was induced using isoflurane and a small custom-built 
head holder was cemented (C&B Superbond) to the skull just anterior to the lambda landmark. Following the sur-
gery, animals were isolated and closely surveyed for 48 h. Buprenorphine (0.05 mg/kg) was provided for postop-
erative analgesia and care was taken to avoid hypothermia and dehydration. Surgery was performed on wild-type 
mice and AhR KO mice, either between postnatal day 21 and 24 (P21–24) for the experiment on the onset of 
nystagmus, or at postnatal day 56 (P56) for the characterization of adult nystagmus and optokinetic deficit tests.
Data acquisition. The experimental set-up and methods of data acquisition and analysis used to record eye 
movements were similar to those previously described9. Briefly, Mice were head-fixed at a ~30° nose-down posi-
tion to align the horizontal canals in the yaw plane. Animals were placed in a custom built Plexiglas tube, and 
eye movements were recorded using an infrared video system (ETL-200, ISCAN, Burlington MA). Eye position 
signals were sampled at 1 kHz, digitally recorded (CED power1401 MkII) with the Spike 2 software and later 
exported into the Matlab (The MathWorks) programming environment for off-line analysis.
Data analysis. Horizontal and vertical eye movement data were digitally low pass-filtered (cut-off frequency: 
40 Hz), and position data were differentiated to obtain velocity traces. Segments of data with saccades were 
excluded from analysis. The frequency and the amplitude of the nystagmus were measured using custom-made 
software written in Matlab (Mathworks). Because AhR KO mice show spontaneous nystagmus, OKR responses 
were measured as the mean eye velocities on segments longer than 2/Fn where Fn is the measured frequency of 
the spontaneous nystagmus. OKR gains were then calculated as the ratios of the mean eye velocities to the con-
stant visual stimulus velocity.
Protocol for eye movement recordings. Mice were securely head-fixed in the apparatus and isolated from the 
experimental room under a 40 cm wide dome. All sources of light were turned off except for the optokinetic 
projector. Light intensity inside the dome was measured at 185 Lux during light conditions and <0.02 Lux during 
dark conditions (Luxmeter Lux-1337 Iso-tech). The different tests were performed as follows: i) animals were 
left unperturbed during an initial accommodation period of 5 minutes; ii) spontaneous eye movements were 
recorded in the light and then under dark conditions. Recordings typically lasted between 3–6 min for each con-
dition; iii) in adults, visuo-motor responses were tested further during optokinetic stimulation. Optokinetic full 
field stimulation was performed by projecting a dotted pattern at velocities in a range of 2.5–7.5°/s in alternated 
clockwise and counter-clockwise directions (S. Fig. 1c). The dotted pattern consisted of 25000 white dots (max 
width 0.075°) randomly distributed on a black background. Visual stimulations lasted 1 min and were separated 
by 2 min in the dark. Analysis was performed as previously reported9.
Anatomical staining using CTB. Optic nerves fiber projections were visualized using an anatomical stain-
ing and ultramicroscopy method in 5 WT mice and 7 AhR KO mice aged 9 to 29 weeks31. The animals were 
anaesthetized using a mixture of ketamine (80 mg/kg) and xylazine (15 mg/kg) injected intra-peritoneally. Alexa 
488 or Alexa 594 conjugated to cholera toxin subunit B (CTB; Life Technologies, France) were diluted in PBS 
(2 µg/mL), and 2 µL of either solution was injected into the vitreous humor of the right or left eye, respectively. 
After 3 days, the mice were deeply anesthetized, perfused and the brains removed and post-fixed for a 3–4 hours 
in PFA 4% in PBS. Then, the brains were made transparent using an adapted version of the 3DISCO method32. 
They were incubated in the following solution at room temperature under agitation: overnight in 50% tetrahy-
drofuran (THF, Sigma-Aldrich, France), 2 h in 80% THF, two times 1 h in 100% THF, 45 min in dichloromethane 
(DCM, Sigma-Aldrich, France) and finally in dibenzylether (DBE, Sigma-Aldrich, France) for storage until image 
acquisition. Ultramicroscopy was then performed using a 100% quartz imaging reservoir where the light sheet 
illuminates and crosses cleared samples31. Sheet serial imaging at 488 (power 85%) and 561 nm (power 90%) 
wavelengths were performed (Coherent Sapphire Laser, LaVisionBiotec) in 2 µm incremental steps of the entire 
thalamus using the 4x objective. High-resolution 16 bit images were then processed using Imaris 7.6.1 software, 
and 3D reconstructions of the thalamus were obtained. Only cases with complete retinal fills, showing good stain-
ing of the thalamus, were used for the quantification of the retinal projections. The volumes of the ipsilateral and 
contralateral staining, i.e. the volumes of stained voxels, were then calculated and the ratio R = Vipsi/Vcontra was 
calculated to assess nerve fiber projections.
VEP recordings. Mice were anaesthetized with intraperitoneal injections of ketamine (120 mg/kg) and xyla-
zine (9 mg/kg) for surgery, and a local anesthetic (1% lidocaine) was applied. Tungsten microelectrodes (300–
500 kΩ, FHC) were bilaterally implanted into the binocular zone of the visual cortex (3 mm lateral of lambda) at 
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a depth of 450 µm below the cortical surface corresponding to layer 4; reference electrodes were inserted at the 
brain surface, 2 mm lateral and 1 mm posterior to bregma. Electrodes were secured in place using cyanoacrylate, 
and a post was fixed to the skull anterior to the bregma for head fixation. Recordings were performed 48 h after 
the surgery for recovery; all mice were first habituated to the experimental set-up 24 h before visual evoked poten-
tial (VEPs) recordings. Stimuli consisting of full-field sine wave gratings of 100% contrast with different acuity 
(0, 0.05, 0.15, 0.25, 0.35, 0.45, 0.55 or 0.65 cycles per degree or cpd) or of 0.05 cpd with different contrast (100, 
50, 25, 12.5, 6, 3 or 1.5%) were presented at 20 cm in front of the animal on a 17-inch cathode ray tube monitor. 
Visual acuity and contrast sensitivity were determined by the trough-to-peak VEP amplitude of the 120 averaged 
responses per condition (8 blocks, 15 presentations in random order). Visual thresholds, corresponding to noise 
level, are represented as dashed lines (Figs 1e and 3c right) and were calculated using the VEP amplitude during 
the presentation of a grey screen. For all mice, the data from the bilateral electrodes were pooled. All recordings 
were amplified, band pass filtered (between 0.4 and 100 Hz) and acquired with a Micro3-1401 digitizer (CED 
Cambridge). Off-line analysis was performed under spike2 environment.
Transmission electron microscopy. Ultrathin sections (50–90 nm) of optic nerves were cut on an ultra-
microtome (8800 Ultrotome III; LKB Bromma) and collected on 300-mesh nickel grids. Staining was performed 
with 4% (vol/vol) aqueous uranyl acetate, followed by Reynolds lead citrate. Ultrastructural analyses were per-
formed in a JEOL JEM-1011 electron microscope and digitalized with DigitalMicrograph software. Image acqui-
sition was performed at the Cochin Institute imaging facility. The G-ratio (ratio of axon diameter/myelin + axon 
diameter) was determined with ImageJ software (National Institutes of Health). At least 300 randomly selected 
axons were analyzed per animal (5 WT mice and 5 AhR KO mice). Healthy axons were defined on the basis of the 
presence of intact membranes and the normal complement of organelles.
Transcriptome and qRT-PCR analysis. RNA sampling from optic nerves (including tissue extraction, RNA 
purification, checking of RNA purity). Optic nerves were placed in 1 mL of Qiazol® reagent with 2 stainless 
steel beads (Qiagen, Courtaboeuf, France) and were homogenized with a Tissuelyser system (RetschMM300, 
Germany). Total RNA was prepared using the RNeasy Mini Kit following the manufacturer’s instructions 
(Qiagen, Les Ulis, France). The quality of total RNA was monitored with a Nanodrop ND-1000 spectrophotome-
ter (Nanodrop products, Wilmington, DE, USA).
Quantitative real-time PCR. Reverse transcription was performed using the High Capacity cDNA Reverse 
Transcription Kit (Life technology, France) according to the manufacturer’s directions. Then quantitative real 
time polymerase chain reaction was performed with 20 ng of cDNA, with duplicates for each experiment. Table S3 
gives the gene-specific primers. The relative amounts of mRNA were estimated using the ΔΔCT method with 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as the reference gene33.
Transcriptome analysis (including hybridization and analysis). Transcriptome analysis was performed with 
Affymetrix Mouse Gene 1.0 ST arrays (a genome wide array with 28000 probe sets) according to the manufac-
turer’s protocol. Briefly, total RNA (300 ng) was labeled and cRNA (antisens RNA) was synthetized using the 
Affymetrix WT cDNA Synthesis and Amplification Kit. After cleanup protocol, ssDNA (sense single stranded 
DNA) was synthetized, fragmented and labeled with biotin. Biotin-ssDNA was hybridized onto microarrays 
according to the manufacturer’s instructions. After 16 h at 45 °C, microarrays were washed and stained using 
Affymetrix fluidics station 450 and scanned with an AffymetrixGeneArray scanner 3000 7G. Raw data were 
normalized using the Robust Multichip Algorithm (RMA) in Bioconductor R34, 35. Then all quality controls and 
statistics were performed using Partek GS® (version 6.6 Copyright© 2012 Partek Inc., St. Louis, MO, USA). 
Hierarchical clustering (Pearson’s dissimilarity and average linkage) and principal component analysis comprised 
unsupervised exploratory data analyses. These multivariate technics aim to assess data for experimental bias or 
outlier samples. To find differentially expressed genes, classical analysis of variance (ANOVA) was performed for 
each gene and pair wise Tukey’s post hoc tests between groups. p-values and fold changes were used to filter and 
select differentially expressed genes.
Functional analysis and data submission. Interaction, pathway and functional enrichment analyses were carried 
out with IPA (Ingenuity® Systems, www.ingenuity.com, USA). All data obtained by microarray analysis have been 
submitted on GEO Omnibus site.
Immunobloting. Optic nerves were collected into RIPA buffer (PBS, 0,5% deoxycholate, 0,1% SDS, 1% 
NP40) containing protease (1%) and phosphatase (1%) inhibitors (Sigma), in presence of 2 stainless steel beads in 
order to be homogenized with TissueLyser system. Three micrograms of proteins were separated by SDS-PAGE 
and transferred onto a nitrocellulose membrane. The membrane was blocked in 5% skimmed milk during 2 hours, 
followed by overnight incubation at 4 °C with anti-MAG antibodies or β-actin (Abcam, France). After three 
washes with TBS-0,1%Tween20, the membrane was incubated with the corresponding HRP-labeled secondary 
antibodies (Cell Signaling). Then, the membrane was observed using ImageQuant LAS 4000 (GE Healthcare).
Immunofluorescence staining. After sacrifice, optic nerves were removed, postfixed overnight in 4% 
paraformaldehyde at 4 °C, then cryoprotected overnight in 10% sucrose at 4 °C, and subsequently frozen in 
gelatin-sucrose. Optic nerves (10 µm cryostat slices) were permeabilized for one hour with 0,3% Triton-PBS. 
Incubation with GFAP and Iba1 antibodies (Abcam) diluted in 0,3% Triton-PBS was performed overnight. After 
three washes with PBS, optic nerves were incubated with the corresponding Alexa-488-labeled chicken antibod-
ies (Invitrogen). The coverslips were sealed with Dako Paramount Aqueous Mounting Medium Ready-to-use 
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(Invitrogen). Tissues were observed and images recorded using an Epifluo Nikon Eclipse TE-2000E microscope 
with Plan fluor 10x/0,30,DIC L/N1, O.N = 0,30, D.T = 16 mm.
Ex vivo culture and treatment. Primary glial cells (oligodendrocytes and astrocytes) were prepared 
from P2–3 mouse brain from WT or AhR KO mice. Briefly, meninges were removed and cerebral hemispheres 
were mechanically dissociated in medium. Cell suspensions were plated in six-well plates coated with 20 µg/mL 
poly-D-lysine (Sigma-Aldrich). Cells were then incubated during 21 days in vitro (DIV21) in 5% CO2 in humid-
ified atmosphere at 37 °C. Finally, cells were treated with 0,1% BSA-PBS (control), TNF-α (R&D Systems), IFN-γ 
(Peprotech) or the mixture.
Statistical analyses. Unless otherwise specified, two group comparisons were performed by Mann–
Whitney’s U-test (nonparametric comparison of two independent series). For primary mixed glial cell cultures 
experiments, multiple group comparisons were performed by Kruskal-Wallis test followed by a pair wise Dunn’s 
post hoc test (nonparametric comparison of multiple independent series). A p-value < 0.05 was considered as 
statistically significant (***p < 0.001, **p < 0.01; *p < 0.05). The values are expressed as the mean ± SEM.
A complementary description of material and methods used in this article is provided in the supplementary 
material.
Data availability statement. All data are fully available upon request.
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